造血干细胞-话题@MedSci

#造血干细胞#

227篇内容 | 6108人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1271486, encodeId=171e12e148696, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Blood：染色质结合蛋白Phf6可限制造血干细胞自我更新, objectType=article, longId=164290, objectId=28bf164290eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28bf164290eb, replyNumber=0, likeNumber=83, createdTime=2019-04-16, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28bf164290eb, moduleTitle=Blood：染色质结合蛋白Phf6可限制造血干细胞自我更新, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28bf164290eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271485, encodeId=29c812e148519, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Blood：Asrij/OCIAD1可抑制CSN5介导的p53降解，维持造血干细胞静态, objectType=article, longId=164176, objectId=fcda1641e6a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fcda1641e6a6, replyNumber=0, likeNumber=64, createdTime=2019-04-14, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fcda1641e6a6, moduleTitle=Blood：Asrij/OCIAD1可抑制CSN5介导的p53降解，维持造血干细胞静态, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fcda1641e6a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271484, encodeId=71e012e148479, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Blood：循环血中的肿瘤DNA可用于预测AML/MDS患者造血干细胞移植后的复发风险, objectType=article, longId=163732, objectId=7ea3163e3222, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ea3163e3222, replyNumber=0, likeNumber=71, createdTime=2019-04-08, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ea3163e3222, moduleTitle=Blood：循环血中的肿瘤DNA可用于预测AML/MDS患者造血干细胞移植后的复发风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ea3163e3222)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271483, encodeId=300712e148392, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=2019 EBMT共识建议：单倍体造血干细胞移植供者的选择, objectType=article, longId=162846, objectId=a92e16284603, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a92e16284603, replyNumber=0, likeNumber=24, createdTime=2019-03-25, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a92e16284603, moduleTitle=2019 EBMT共识建议：单倍体造血干细胞移植供者的选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a92e16284603)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271482, encodeId=3f3712e148285, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Blood：抗CD117抗体可同时清除正常的和异常的造血干细胞！, objectType=article, longId=162489, objectId=d00416248941, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d00416248941, replyNumber=0, likeNumber=69, createdTime=2019-03-18, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d00416248941, moduleTitle=Blood：抗CD117抗体可同时清除正常的和异常的造血干细胞！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d00416248941)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271481, encodeId=d1e812e148191, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=ECIL-7指南：造血干细胞移植受者的疫苗接种, objectType=article, longId=160689, objectId=6db6160689a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6db6160689a0, replyNumber=0, likeNumber=27, createdTime=2019-02-22, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6db6160689a0, moduleTitle=ECIL-7指南：造血干细胞移植受者的疫苗接种, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6db6160689a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271480, encodeId=36cd12e1480fa, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Blood：内皮蛋白C受体（Epcr）可促进造血干细胞植入Mpl缺陷型小鼠并扩增, objectType=article, longId=159656, objectId=8fd115965637, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8fd115965637, replyNumber=0, likeNumber=71, createdTime=2019-02-10, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8fd115965637, moduleTitle=Blood：内皮蛋白C受体（Epcr）可促进造血干细胞植入Mpl缺陷型小鼠并扩增, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8fd115965637)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271479, encodeId=557112e1479b3, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=造血干细胞移植治疗淋巴瘤中国专家共识（2018版）, objectType=article, longId=159443, objectId=887a15944304, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=887a15944304, replyNumber=0, likeNumber=26, createdTime=2019-02-04, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=887a15944304, moduleTitle=造血干细胞移植治疗淋巴瘤中国专家共识（2018版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=887a15944304)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271478, encodeId=d5f612e147843, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Blood：内皮糖蛋白对维持造血干细胞静止至关重要, objectType=article, longId=158679, objectId=ad151586e929, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad151586e929, replyNumber=0, likeNumber=85, createdTime=2019-01-24, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad151586e929, moduleTitle=Blood：内皮糖蛋白对维持造血干细胞静止至关重要, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad151586e929)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271477, encodeId=e26712e14775a, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=J Hematol Oncol：套细胞淋巴瘤自体造血干细胞移植后硼替佐米+利妥昔单抗疗效喜人, objectType=article, longId=155661, objectId=4497155661dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4497155661dc, replyNumber=0, likeNumber=74, createdTime=2018-12-14, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4497155661dc, moduleTitle=J Hematol Oncol：套细胞淋巴瘤自体造血干细胞移植后硼替佐米+利妥昔单抗疗效喜人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4497155661dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271476, encodeId=655612e1476d3, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=东航被指拒载造血干细胞储运箱客服回复：手续不全, objectType=article, longId=154983, objectId=0d2015498316, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d2015498316, replyNumber=0, likeNumber=68, createdTime=2018-12-04, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d2015498316, moduleTitle=东航被指拒载造血干细胞储运箱客服回复：手续不全, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0d2015498316)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271475, encodeId=d8d712e1475d1, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Sci Transl med:白血病患者福音！新发现有望提高“造血干细胞移植”成功率, objectType=article, longId=154892, objectId=d81d154892f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d81d154892f4, replyNumber=0, likeNumber=57, createdTime=2018-12-02, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d81d154892f4, moduleTitle=Sci Transl med:白血病患者福音！新发现有望提高“造血干细胞移植”成功率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d81d154892f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271474, encodeId=f0ae12e147417, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=JAMA ONCOL：造血干细胞移植后继发实体瘤患者预后评估, objectType=article, longId=154724, objectId=8010154e24c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8010154e24c4, replyNumber=0, likeNumber=97, createdTime=2018-12-01, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8010154e24c4, moduleTitle=JAMA ONCOL：造血干细胞移植后继发实体瘤患者预后评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8010154e24c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271473, encodeId=38ab12e14734c, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=2018 EWALL/EBMT立场声明：造血干细胞移植治疗成人费城染色体阴性急性淋巴细胞白血病首次缓解, objectType=article, longId=153017, objectId=649b15301eb0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=649b15301eb0, replyNumber=0, likeNumber=25, createdTime=2018-11-09, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=649b15301eb0, moduleTitle=2018 EWALL/EBMT立场声明：造血干细胞移植治疗成人费城染色体阴性急性淋巴细胞白血病首次缓解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=649b15301eb0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271472, encodeId=c20912e1472fa, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Blood：双重胆碱能信号调控造血干细胞和白细胞在骨髓和外周血之间的日夜转移, objectType=article, longId=151986, objectId=509c1519867a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=509c1519867a, replyNumber=0, likeNumber=68, createdTime=2018-10-29, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=509c1519867a, moduleTitle=Blood：双重胆碱能信号调控造血干细胞和白细胞在骨髓和外周血之间的日夜转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=509c1519867a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271471, encodeId=ff8812e1471f7, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Blood：αβT/B细胞敲除后进行HLA相合性造血干细胞移植（αβhaplo-HSCT）可有效治疗急性白血病, objectType=article, longId=151767, objectId=d624151e67f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d624151e67f4, replyNumber=0, likeNumber=64, createdTime=2018-10-25, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d624151e67f4, moduleTitle=Blood：αβT/B细胞敲除后进行HLA相合性造血干细胞移植（αβhaplo-HSCT）可有效治疗急性白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d624151e67f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271470, encodeId=0cbc12e1470cd, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Stem cells：骨髓间充质干细胞分泌的微泡可提高造血干细胞的移植效率, objectType=article, longId=150776, objectId=51a6150e762a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51a6150e762a, replyNumber=0, likeNumber=130, createdTime=2018-10-12, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51a6150e762a, moduleTitle=Stem cells：骨髓间充质干细胞分泌的微泡可提高造血干细胞的移植效率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=51a6150e762a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271469, encodeId=275612e146984, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Nat Commun：中科院刘小龙研究组合作揭示调控造血干细胞髓系分化潜能的分子机制, objectType=article, longId=149940, objectId=b80814994008, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b80814994008, replyNumber=0, likeNumber=72, createdTime=2018-09-30, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b80814994008, moduleTitle=Nat Commun：中科院刘小龙研究组合作揭示调控造血干细胞髓系分化潜能的分子机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b80814994008)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271468, encodeId=bc7712e1468f8, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=2018 中国白血病异基因造血干细胞移植后复发的监测，治疗和预防共识（英文版）, objectType=article, longId=149148, objectId=44dc1491489b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44dc1491489b, replyNumber=0, likeNumber=27, createdTime=2018-09-21, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44dc1491489b, moduleTitle=2018 中国白血病异基因造血干细胞移植后复发的监测，治疗和预防共识（英文版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44dc1491489b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271467, encodeId=55f412e1467fc, content=<a href='/topic/show?id=a0ff950018f' target=_blank style='color:#2F92EE;'>#造血干细胞#</a>, objectTitle=Cell Research第三次聚焦m6A修饰与成体造血干细胞调控, objectType=article, longId=147754, objectId=64c414e754b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64c414e754b0, replyNumber=0, likeNumber=52, createdTime=2018-09-01, rootId=0, userName=huanbaofeng, userId=e729101, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64c414e754b0, moduleTitle=Cell Research第三次聚焦m6A修饰与成体造血干细胞调控, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64c414e754b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

造血干细胞

2020-05-29

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Blood：染色质结合蛋白Phf6可限制造血干细胞自我更新

2019-04-16

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Blood：Asrij/OCIAD1可抑制CSN5介导的p53降解，维持造血干细胞静态

2019-04-14

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Blood：循环血中的肿瘤DNA可用于预测AML/MDS患者造血干细胞移植后的复发风险

2019-04-08

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

2019 EBMT共识建议：单倍体造血干细胞移植供者的选择

2019-03-25

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Blood：抗CD117抗体可同时清除正常的和异常的造血干细胞！

2019-03-18

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

ECIL-7指南：造血干细胞移植受者的疫苗接种

2019-02-22

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Blood：内皮蛋白C受体（Epcr）可促进造血干细胞植入Mpl缺陷型小鼠并扩增

2019-02-10

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

造血干细胞移植治疗淋巴瘤中国专家共识（2018版）

2019-02-04

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Blood：内皮糖蛋白对维持造血干细胞静止至关重要

2019-01-24

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

J Hematol Oncol：套细胞淋巴瘤自体造血干细胞移植后硼替佐米+利妥昔单抗疗效喜人

2018-12-14

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

东航被指拒载造血干细胞储运箱客服回复：手续不全

2018-12-04

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Sci Transl med:白血病患者福音！新发现有望提高“造血干细胞移植”成功率

2018-12-02

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

JAMA ONCOL：造血干细胞移植后继发实体瘤患者预后评估

2018-12-01

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

2018 EWALL/EBMT立场声明：造血干细胞移植治疗成人费城染色体阴性急性淋巴细胞白血病首次缓解

2018-11-09

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Blood：双重胆碱能信号调控造血干细胞和白细胞在骨髓和外周血之间的日夜转移

2018-10-29

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Blood：αβT/B细胞敲除后进行HLA相合性造血干细胞移植（αβhaplo-HSCT）可有效治疗急性白血病

2018-10-25

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Stem cells：骨髓间充质干细胞分泌的微泡可提高造血干细胞的移植效率

2018-10-12

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Nat Commun：中科院刘小龙研究组合作揭示调控造血干细胞髓系分化潜能的分子机制

2018-09-30

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

2018 中国白血病异基因造血干细胞移植后复发的监测，治疗和预防共识（英文版）

2018-09-21

huanbaofeng (审核中...)

前往app查看评论内容

#造血干细胞#

Cell Research第三次聚焦m6A修饰与成体造血干细胞调控

2018-09-01

科室
- - 订阅+
  - 更多科室
工具
服务